cumulus-neuroscience
2 known investors
Cumulus Neuroscience develops the NeuLogiq platform, which combines digital cognitive assessments and neurophysiological (brain function) data for in-clinic and at-home longitudinal monitoring. It serves pharmaceutical companies and researchers running CNS clinical trials, providing objective real-world endpoints to support central nervous system drug development.